Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis

被引:84
作者
Szabó, E [1 ]
Páska, C [1 ]
Novák, PK [1 ]
Schaff, Z [1 ]
Kiss, A [1 ]
机构
[1] Semmelweis Univ, Dept Pathol 2, H-1091 Budapest, Hungary
关键词
hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; hepatocarcinogenesis;
D O I
10.1007/BF02893401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC), the major manifestation of primary liver cancer, is one of the most frequent and malignant diseases worldwide. Among other environmental factors, hepatitis viruses, as the hepatitis B (HBV) and hepatitis C (HCV) viruses, are to be listed in the etiology of HCC. Both of these viruses cause a wide spectrum of clinical manifestations, ranging from healthy carrier state to acute and chronic hepatitis, cirrhosis and HCC. HBV and HCV are different viruses in structure: HBV contains a DNA genome which replicates through an RNA intermediate and requires an active viral reverse transcriptase (RT) polymerase enzyme, while HCV is an RNA virus which has no RT activity and replicates on the cellular membrane by RNA replication. In this review we discuss how these two biologically diverse viruses use common pathways to induce hepatocarcinogenesis despite their significant structural and viral cycle differences. A summary is also given of several observable common and different features. Direct integration of HBV viral sequences into the host genome increases the genomic instability, which does not occur in HCV infection. However, viral proteins may directly play a significant role in the induction of carcinogenesis by both viruses.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 54 条
[1]   Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[2]  
Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.0.CO
[3]  
2-6
[4]  
Andrisani OM, 1999, INT J ONCOL, V15, P373
[5]  
[Anonymous], 5 IARC
[6]   Hepatocellular carcinoma: an overview [J].
Anthony, PP .
HISTOPATHOLOGY, 2001, 39 (02) :109-118
[7]  
BOSCH FX, 1997, LIVER CANCER, P13
[8]   Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) [J].
Bréchot, C ;
Gozuacik, D ;
Murakami, Y ;
Paterlini-Bréchot, P .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :211-231
[9]  
Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185
[10]   Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives [J].
Chen, PJ ;
Chen, DS .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :253-262